Volume 99, Issue 1

Search all Annals of Hematology articles

January 2020

32 articles in this issue

Systematic review on the value of end-of-treatment FDG-PET in improving overall survival of lymphoma patients
Hugo J.A. Adams
Thomas C. Kwee
Review Article Open access 07 December 2019 Pages: 1 - 5
The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion
Sophie Park
Charikleia Kelaidi
Uwe Platzbecker
Review Article Open access 25 October 2019 Pages: 7 - 19
Correction to: The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion
Sophie Park
Charikleia Kelaidi
Uwe Platzbecker
Correction Open access 02 December 2019 Pages: 21 - 21
A novel SNP rs11759328 on Rho GTPase-activating protein 18 gene is associated with the expression of Hb F in hemoglobin E-related disorders
Wittaya Jomoui
Wanicha Tepakhan
Supan Fucharoen
Original Article 27 November 2019 Pages: 23 - 29
Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia
Rasha Abd El-Rahman El-Gamal
Ibrahim Youssef Abdel-Messih
Shaimaa Abdelmalik Pessar
Original Article 13 December 2019 Pages: 31 - 39
The increased neopterin content in turkish pediatric patients with sickle cell anemia
Suna Sabuncuoğlu
Yeşim Öztaş
Gözde Girgin
Original Article 23 November 2019 Pages: 41 - 47
Evaluation of thrombotic events in patients with immune thrombocytopenia
Shoko Ito
Shin-ichiro Fujiwara
Yoshinobu Kanda
Original Article 18 December 2019 Pages: 49 - 55
Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia
Rahul Kaundal
Prateek Bhatia
Deepesh P. Lad
Original Article 06 December 2019 Pages: 57 - 63
Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice
Massimo Breccia
Claudia Baratè
Francesca Palandri
Original Article Open access 12 December 2019 Pages: 65 - 72
The predictive value of minimal residual disease when facing the inconsistent results detected by real-time quantitative PCR and flow cytometry in NPM1-mutated acute myeloid leukemia
Meng-Ge Gao
Guo-Rui Ruan
Xiao-Su Zhao
Original Article 25 November 2019 Pages: 73 - 82
Prognostic significance of FDG-PET/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas
Seo-Yeon Ahn
Seung-Yeon Jung
Deok-Hwan Yang
Original Article 06 December 2019 Pages: 83 - 91
Primary central nervous system lymphoma in China: a single-center retrospective analysis of 167 cases
Xiang-Gui Yuan
Yu-Rong Huang
Xiao-Ying Zhao
Original Article 22 November 2019 Pages: 93 - 104
R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial
Andrea Kühnl
Clare Peckitt
David Cunningham
Original Article 27 November 2019 Pages: 105 - 112
Clinical impact of the CONUT score in patients with multiple myeloma
Sho Okamoto
Hiroshi Ureshino
Shinya Kimura
Original Article 25 November 2019 Pages: 113 - 119
The incidence of thromboembolism for lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma
Ang Li
Qian Wu
Gary H. Lyman
Original Article 26 November 2019 Pages: 121 - 126
Visual and volumetric parameters by 18F-FDG-PET/CT: a head to head comparison for the prediction of outcome in patients with multiple myeloma
Rosa Fonti
Sara Pellegrino
Leonardo Pace
Original Article 27 November 2019 Pages: 127 - 135
Sequential therapy of four cycles of bortezomib, melphalan, and prednisolone followed by continuous lenalidomide and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma
Reiko Isa
Nobuhiko Uoshima
Kyoto Clinical Hematology Study Group investigators
Original Article 25 November 2019 Pages: 137 - 145
Unmanipulated haploidentical hematopoietic stem cell transplantation using very low-dose antithymocyte globulin and methylprednisolone in adults with relapsed/refractory acute leukemia
Tatsuya Konishi
Noriko Doki
Kazuteru Ohashi
Original Article 30 November 2019 Pages: 147 - 155
When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine)
Albert Esquirol
Sergi Querol
Jorge Sierra
Original Article 17 December 2019 Pages: 157 - 165
Reduced risk of chronic GVHD by low-dose rATG in adult matched sibling donor peripheral blood stem cell transplantation for hematologic malignancies
Liping Dou
Cheng Hou
Daihong Liu
Original Article Open access 11 December 2019 Pages: 167 - 179
Daratumumab-associated hemophagocytic lymphohistiocytosis
Ashley Woods
Melanie Wooten
Edmund Waller
Letter to the Editor 17 December 2019 Pages: 181 - 182
Atypical mycobacteria diagnosed by bone marrow biopsy in an HIV-positive patient
Magda Zanelli
Maurizio Zizzo
Stefano Ascani
Letter to the Editor 06 December 2019 Pages: 183 - 184
MEF2D-rearranged acute lymphoblastic leukemia resembles Burkitt lymphoma/leukemia
Jiewen Sun
Wenjuan Yu
Xiang Zhang
Letter to the Editor 28 November 2019 Pages: 185 - 188
Prognostic significance of hyperfibrinogenemia in patients with lower-risk myelodysplastic syndromes
Shinji Ogura
Shoichiro Yonei
Tomonori Nakazato
Letter to the Editor 26 November 2019 Pages: 189 - 191
Bilateral vision loss in Waldenstrom’s macroglobulinemia
Vasiliki Vasileiou
Maria Kotoula
Eleni Papageorgiou
Letter to the Editor 07 December 2019 Pages: 193 - 194
Systemic mastocytosis associated with acute myeloid leukemia
Frederico Lisboa Nogueira
Naira Neves Neto Martins
Evandro Maranhão Fagundes
Letter to the Editor 25 November 2019 Pages: 195 - 196
Congenital dyserythropoietic anemia type I mimicking myelodysplasia syndrome with a novel CDAN1 mutation
Xueyan Lv
Shanwu Dong
Runming Jin
Letter to the Editor 23 November 2019 Pages: 197 - 199
A case of polycyclic Sweet’s syndrome arising from azacitidine injection sites in myelodysplasia
William A. Berry
Robert Kelly
Letter to the Editor 09 December 2019 Pages: 201 - 202
Magnetic resonance imaging and ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography findings in neurolymphomatosis: an uncommon presentation of diffuse large B cell lymphoma
Marta D. Switlyk
Annette T. Skeie
Bjørn Østenstad
Letter to the Editor 25 November 2019 Pages: 203 - 205
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT
Livio Pagano
Alessio Maria Edoardo Maraglino
Valerio De Stefano
Letter to the Editor 12 December 2019 Pages: 207 - 209
Iron deficiency: an independent prognostic marker in heart failure
Kamal Kant Sahu
Ajay Kumar Mishra
Ahmad Daniyal Siddiqui
Letter to the Editor 09 December 2019 Pages: 211 - 212
Correction to: Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores
Hyewon Lee
Yu Ri Kim
Jin Seok Kim
Correction 16 December 2019 Pages: 213 - 213

Volume 99, Issue 1

Systematic review on the value of end-of-treatment FDG-PET in improving overall survival of lymphoma patients

The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion

Correction to: The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion

A novel SNP rs11759328 on Rho GTPase-activating protein 18 gene is associated with the expression of Hb F in hemoglobin E-related disorders

Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia

The increased neopterin content in turkish pediatric patients with sickle cell anemia

Evaluation of thrombotic events in patients with immune thrombocytopenia

Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia

Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice

The predictive value of minimal residual disease when facing the inconsistent results detected by real-time quantitative PCR and flow cytometry in NPM1-mutated acute myeloid leukemia

Prognostic significance of FDG-PET/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas

Primary central nervous system lymphoma in China: a single-center retrospective analysis of 167 cases

R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial

Clinical impact of the CONUT score in patients with multiple myeloma

The incidence of thromboembolism for lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma

Visual and volumetric parameters by 18F-FDG-PET/CT: a head to head comparison for the prediction of outcome in patients with multiple myeloma

Sequential therapy of four cycles of bortezomib, melphalan, and prednisolone followed by continuous lenalidomide and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma

Unmanipulated haploidentical hematopoietic stem cell transplantation using very low-dose antithymocyte globulin and methylprednisolone in adults with relapsed/refractory acute leukemia

When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine)

Reduced risk of chronic GVHD by low-dose rATG in adult matched sibling donor peripheral blood stem cell transplantation for hematologic malignancies

Daratumumab-associated hemophagocytic lymphohistiocytosis

Atypical mycobacteria diagnosed by bone marrow biopsy in an HIV-positive patient

MEF2D-rearranged acute lymphoblastic leukemia resembles Burkitt lymphoma/leukemia

Prognostic significance of hyperfibrinogenemia in patients with lower-risk myelodysplastic syndromes

Bilateral vision loss in Waldenstrom’s macroglobulinemia

Systemic mastocytosis associated with acute myeloid leukemia

Congenital dyserythropoietic anemia type I mimicking myelodysplasia syndrome with a novel CDAN1 mutation

A case of polycyclic Sweet’s syndrome arising from azacitidine injection sites in myelodysplasia

Magnetic resonance imaging and ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography findings in neurolymphomatosis: an uncommon presentation of diffuse large B cell lymphoma

Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT

Iron deficiency: an independent prognostic marker in heart failure

Correction to: Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores

Navigation